Enanta Pharmaceuticals Inc (ENTA NASDAQ) stock market data APIs
$11.0475
0.4(3.6%)
as of October 14, 2025
Try our APIs with
free plan!
Enanta Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
Prev. Close
11.0475
Open
11.4477
High
11.4012
Low
10.9362
52 wk Range
4.09-15.34
Market Cap
332 M
Shares Outstanding
28 853 K
Revenue
64 806 K
EPS
-0.85
Beta
0.894
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Enanta Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Enanta Pharmaceuticals Inc data using free add-ons & libraries
Get Enanta Pharmaceuticals Inc Fundamental Data
Enanta Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 64 806 K
- EBITDA: -93 036 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-11
- EPS/Forecast: -0.88
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Enanta Pharmaceuticals Inc News
New
Biggest stock movers Wednesday: LAC, NKE, and more
[Electronic highway billboard with government shutdown ahead warning] Richard Stephen Stock futures edged down Wednesday morning as the U.S. government shutdown commenced at midnight with the Senate ...
Enanta pharmaceuticals prices $65M common stock offering
* Enanta Pharmaceuticals (NASDAQ:ENTA [https://seekingalpha.com/symbol/ENTA]) has priced its public offering of 6.5M common shares at $10.00 per share for gross proceeds of $65.0M. * The company ...
Enanta shares rise despite RSV trial failing to meet main goal
[RSV, respiratory syncytial virus, human orthopneumovirus, contagious child disease] BeritK/iStock via Getty Images Enanta Pharmaceuticals (NASDAQ:ENTA [https://seekingalpha.com/symbol/ENTA]) shares ...
Enanta's Oral Antiviral Shows Key Benefit For High-Risk Adults With RSV In Phase 2b Trial; Stock Up
(RTTNews) - Enanta Pharmaceuticals Inc. (ENTA) has reported topline data from its RSVHR study of Zelicapavir, demonstrating a clinically meaningful benefit in high-risk adults infected with RSV. RSVH...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
